DMCC Q2 FY27: Revenue surges 116% YoY but consolidated PAT falls 44% as margins collapse

DMCC's consolidated revenue continued to compound, up 116.5% YoY to ₹272.88 Cr (+7.9% QoQ from ₹253.01 Cr), but consolidated PAT fell 43.9% YoY to ₹3.23 Cr and collapsed 84.2% QoQ from ₹20.40 Cr — EPS ₹1.29 versus ₹2.31 a year ago and ₹8.18 last quarter. The profitability reversal was flagged by management itself: at the Q1 FY27 print the company explicitly warned that "a meaningful portion of the reported profitability reflects inventory gains... these gains will reverse as prices moderate, and profits will normalise" — this quarter's print satisfies that warning almost to the letter, so against management's own prior guidance the result is a clean 'met', not a surprise. No formal Street consensus for Q2 FY27 specifically surfaced in available coverage; the closest market reference is a ~15-20% full-year FY27 PAT growth assumption underlying recent analyst price targets, a bar H1 FY27's ₹23.63 Cr consolidated PAT (+75% YoY) still clears on a half-year basis even after this quarter's reversal.

The compression sits squarely in the raw-material line: consumption of raw materials rose to 86.4% of revenue this quarter, up from 78.1% in Q1 FY27 and 67.9% a year ago, pulling operating margin down to 1.46% from 13.49% QoQ and net margin to 1.18% from 8.06% QoQ / 4.55% YoY. Total expenses grew faster than income quarter-on-quarter, and finance costs also rose to ₹3.83 Cr from ₹1.91 Cr YoY on higher short-term borrowings (₹66.52 Cr versus ₹49.62 Cr at FY26-end), adding a secondary drag below the operating line.

The stock went into the print at ₹257.55, down 18.7% over the past month of trading.

Standalone and consolidated are near-identical this quarter (PAT ₹3.21 Cr standalone versus ₹3.23 Cr consolidated) — the German subsidiary remains immaterial. The continued revenue doubling is consistent with the cautiously optimistic "FY27 better than FY25-26" framing management gave on the Q4 FY26 call, including early commercial traction in boron derivatives, but that call's qualitative outlook said nothing about the margin trajectory now playing out. Separately, BSE sought and received a clarification from the company on October 7, 2026 over unusual trading-volume/price movement in the stock; management attributed it to market conditions, unrelated to this quarter's operating numbers. No management press release accompanying this specific result was available to cross-check framing beyond the regulatory filing itself.